Yaacov Lawrence

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He is a Fellow of ASTRO (FASTRO), an honor in radiation oncology. He specializes in precision radiation therapy and neuro-oncology for specific cancer cases.

Precision Radiation Oncology & Specialization

Dr. Lawrence uses radiation therapy to treat various malignant conditions. He achieves treatment outcomes for his patients while reducing side effects. The specialist performs stereotactic radiosurgery for brain tumors and intracranial lesions — a procedure that uses high doses of radiation to destroy tumor cells without traditional surgery.

He leads the GI Cancer Program at Sheba Medical Center for gastrointestinal oncology. Dr. Lawrence pioneered celiac plexus radiosurgery to treat severe pain from pancreatic cancer. This non-invasive technique helps patients manage symptoms of advanced abdominal diseases. Because the approach is non-invasive, patients avoid the risks of traditional surgical methods.

The doctor also provides care for lung and prostate cancers. He integrates translational research directly into clinical protocols to achieve personalized treatment. His methods include combining immunotherapy with targeted radiation doses. This combination helps the body's immune system recognize and attack cancer cells more effectively.

Academic & Leadership Roles

• Chair of the Radiation Oncology Department at Sheba Medical Center
• Director of the Center for Translational Radiation Oncology
• Associate Professor at Tel Aviv University
• Former Assistant Professor at Thomas Jefferson University

Education & Professional Training

• MBBS – University College London Hospital (UCLH)
• MA – University of Cambridge
• Radiation Oncology Fellowship – Thomas Jefferson University
• Member of the Royal College of Physicians (MRCP)

Scientific Contributions & Awards

Dr. Lawrence has authored over 280 scientific publications in international journals. His research focuses on biomarkers and personalized radiation therapy protocols. He also studies treatment strategies for cancers and nervous system tumors.

The doctor received the ASCO Young Investigator Award for his research contributions. This award recognizes early-career physicians for their work in clinical oncology research. He presents his findings on immunotherapy and radiation combinations at congresses. He develops next-generation radiation techniques to improve patient outcomes.

Professional Memberships

• Fellow of the American Society for Radiation Oncology (FASTRO)
• Member of the American Society of Clinical Oncology (ASCO)
• Member of the Royal College of Physicians (RCP)